On next-gen GLP-1 drugs. “A mere decade ago, obesity drugs powerful enough…
On next-gen GLP-1 drugs. “A mere decade ago, obesity drugs powerful enough for people to routinely drop double-digit percentages of their body weight were unheard-of. Today, there are two, and they feel ubiquitous.” 💬 Join the discussion on kottke.org →
World Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications – ABC News
World Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications ABC News WHO warning over shortage of obesity jabs BBC Shortage of ‘breakthrough’ weight loss drugs will slow fight against obesity, WHO warns The Guardian WHO issues global guideline on the use of GLP-1 medicines in treating obesity World Health Organization (WHO) WHO recommends GLP-1 drugs […]
WHO releases its first guidelines on GLP-1s
The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this guidance aimed to help reduce the “skyrocketing health costs” associated with obesity, which are projected to have a global economic cost of…
Urgent warning as ‘essential’ fat jabs are available to less than one in ten obese people who need them
FEWER than one in ten of the world’s billion obese people can access weight-loss jabs, according to the World Health Organisation. High costs, limited production and supply chain problems are preventing the vast majority of overweight people who would benefit from accessing what can be life-saving GLP-1 drugs. The WHO has already classed them as…
WHO backs use of GLP-1 therapies for obesity, warns access will remain limited – Reuters
WHO backs use of GLP-1 therapies for obesity, warns access will remain limited Reuters
Lilly slightly lowers self-pay prices for single-dose vials of Zepbound
Eli Lilly will shave $50 off the self-pay price for most single-dose vials of its blockbuster weight loss drug Zepbound, about a month after agreeing to lower the prices for its multi-dose pens as part …
WHO Guideline on GLP-1 Therapies for Obesity in Adults
This Special Communication summarizes the WHO guideline on the management of obesity with GLP-1 therapies in adults and calls on nations to ensure equitable access to obesity prevention and management interventions.
WHO warning over shortage of obesity jabs – BBC
WHO warning over shortage of obesity jabs BBC WHO recommends GLP-1 drugs for obesity NBC News World Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications ABC News WHO says weight loss drugs are ‘new chapter’ in fight against obesity The Guardian World Health Organization recommends GLP-1s for obesity. There’s a catch. USA Today
Popular fat jab could slow Alzheimer’s by slashing brain shrinkage and boosting memory
A FAT jab could help slow down Alzheimer’s by slashing brain shrinkage, according to a small British study. Liraglutide, the GLP-1 drug already used to manage type 2 diabetes, has sparked fresh hope that weight-loss injections could protect the brain. It comes just days after semaglutide, the ingredient in blockbuster jab Wegovy, was found not to…
WHO recommends Ozempic-style weight loss drugs for obesity
Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease associated with substantial morbidity, mortality, and economic burden.